AOD-9604 (2mg Vial) Dosage Protocol

AOD-9604 (2mg Vial) Dosage Protocol

Quickstart Highlights

AOD-9604 2mg dosage protocol is often employed to assist with fat metabolism and weight management through once-daily subcutaneous injections.

  • Common daily dose range between 300–500 mcg per day
  • Once-daily injection schedule (subcutaneously)
  • Reconstitute with up to 2 mL for easier measuring
  • Store lyophilized in the freezer; reconstituted in the refrigerator
AOD-9604 Vial

Dosing & Reconstitution Guide

Educational guide for reconstitution and dosing protocol

Standard / Gradual Approach (2 mL = ~1,000 mcg/mL)

Week Daily Dosage (mcg) Units (mL)
Weeks 1–8 300 mcg once daily 30 units (0.30 mL)

Ideal for individuals seeking a moderate fat-metabolism protocol. Reconstitute with 2 mL of bacteriostatic water to achieve ~1,000 mcg per mL.

  1. Draw 2.0 mL of bacteriostatic water into a sterile syringe.
  2. Inject water slowly along the vial wall to reduce foaming.
  3. Gently swirl—avoid vigorous shaking.
  4. Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.

Advanced / Aggressive Approach (2 mL = ~1,000 mcg/mL)

Week Daily Dosage (mcg) Units (mL)
Weeks 1–8 500 mcg once daily 50 units (0.50 mL)

Suited for individuals who have used AOD-9604 before or require more aggressive dosing. Reconstitute with 2 mL of bacteriostatic water to achieve ~1,000 mcg per mL.

  1. Draw 2.0 mL of bacteriostatic water into a sterile syringe.
  2. Inject water carefully along the vial wall to reduce foam.
  3. Gently roll/swirl the vial—no vigorous shaking.
  4. Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.

Note: This guide is for educational purposes only. Always consult with a qualified healthcare professional.

Protocol Overview

A concise summary of this daily regimen.

  • Goal: Encourage fat metabolism and weight management
  • Schedule: Daily subcutaneous injections for 8 weeks (extendable to 12 weeks)
  • Dose Range: 300–500 mcg per day
  • Reconstitution: Use ~2 mL for practical dosing (~1,000 mcg/mL)
  • Storage: Keep lyophilized vials frozen; refrigerate after reconstitution

Dosing Protocol

Suggested once-daily injection approach for consistent fat-burning support.

  • Daily Dose: Start at 300 mcg; increase up to 500 mcg as needed
  • Frequency: Inject once per day subcutaneously
  • Cycle Length: 8–12 weeks total
  • Max Dose: 500 mcg daily for advanced users
  • Timing: Often taken in the morning, fasted or 30 minutes before exercise

Storage Instructions

Proper storage ensures peptide integrity.

  • Lyophilized: Freeze until mixing (−20°C)
  • Reconstituted: Refrigerate at 2–8°C
  • Use within 30 days of reconstitution
  • Avoid repeated freeze-thaw cycles

Supplies Needed

Ensure you have these on hand for an 8–12 week cycle.

  • Peptide Vials:
    • 8 wks @ 300 mcg/day → ~9 vials
    • 8 wks @ 500 mcg/day → ~14 vials
    Adjust accordingly for 12+ weeks
  • Insulin Syringes:
    • 1 syringe per day of the cycle
  • Bacteriostatic Water: 1× 30ml
  • Alcohol Swabs: 1 box

Important Notes

Practical tips to enhance safety and efficacy.

  • Always use new, sterile insulin syringes & rotate injection sites.
  • Maintain consistency; daily injections yield the best results.
  • Observe for adverse reactions; consult a professional if concerns arise.
  • Track progress throughout the protocol, adjusting dosage if recommended.

How This Works

AOD-9604 is a modified fragment of human growth hormone that may aid in fat metabolism.

  • Lipolysis Support: Targets stored fat, assisting in its breakdown
  • Potential Fat-Blocking: Inhibits formation of new fat molecules
  • Generally does not affect blood glucose or IGF-1 levels like full hGH

Potential Benefits & Side Effects

Many users observe improved body composition; individual results may vary.

  • May help enhance fat loss and metabolic efficiency
  • Often well-tolerated, with minimal side effects reported
  • Possible mild side effects include injection-site irritation or headache
  • Rarely, users experience brief GI discomfort or dizziness

Lifestyle Factors

Complementary strategies for maximum benefit.

  • Adopt a balanced, nutrient-dense diet
  • Incorporate regular physical activity and adequate rest
  • Manage stress and prioritize consistent sleep patterns

Injection Technique

Simple guidelines for safe daily injections.

  • Clean vial rubber stopper & injection site with alcohol swabs
  • Insert needle at a 45–90° angle into subcutaneous tissue
  • Inject slowly & rotate sites (abdomen, thigh, etc.)

Important Note

This guide is for educational purposes only. Always consult a qualified healthcare provider before starting or modifying any therapy.

References


  • Metabolic Pharmaceuticals Trial
    – PatientPop PDF (Obesity / AOD-9604 Study)

  • FDA Document
    – Regulations Submission (Attachment 4)

  • FDA Document
    – Regulations Submission (Attachment 17)

  • BioSpace
    – Metabolic Pharmaceuticals AOD-9604 Trial Update

  • PMC
    – Article PMC3584306 (Peer-Reviewed Study)

  • Endocrinology Journal
    – AOD-9604 Research (GH Fragment)

  • PubMed
    – PMID: 11146367 (Hormone / Growth Factor Study)

  • Annals of Clinical & Laboratory Science
    – GH Fragments & Lipolysis Study

  • PMC
    – Article PMC3136748 (Peptide-Related Study)

  • Endocrinology Journal (PDF)
    – Advanced GH Fragment Research

  • Journal of Endocrinology & Metabolism
    – AOD-9604 Discussion (Article 157/194)

  • FDA Document
    – 2015-N-3534-0283 (Attachment 4)

  • Elite Plastic Surgery AZ
    – Peptide Therapy Insights

  • Google Patents
    – Patent WO2007033427A1 (GH Fragment Methods)

  • Journal of Endocrinology & Metabolism
    – AOD-9604 Clinical Usage (Article 213/278)